SLC6A3 and Parkinson disease: (2) Patients in the PD group with moderate‐to‐severe WMHs had a higher risk of developing LID than those in the PD group with minimal WMHs, after adjustment for confounding factors such as age at onset, sex, striatal DAT availability, and doses of PD medications.